-
Alternative_name
INCB-018424 (R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile phosphate INC-424 INCB018424
-
Description
Ruxolitinib phosphate is the phosphate salt form of ruxolitinib, a potent Janus-associated kinase (JAK) inhibitor with potential antineoplastic and immunomodulating activities. Ruxolitinib specifically binds to and inhibits protein tyrosine kinases JAK 1 and 2, which may lead to a reduction in inflammation and an inhibition of cellular proliferation.
-
CAS Number
1092939-17-7
-
Structure Available
Yes
-
Salt Form
No
-
Molecular Formula
C₁₇H₂₁N₆O₄P
-
Molecular Weight
404.37
-
Cell Permeable
True
-
Purity
≥98% by HPLC
-
Solubilities
>30 mg/ml in DMSO
-
Handling
Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
-
Tag Line
A potent Janus Kinase (JAK) inhibitor
-
Storage Condition
-20ºC
-
Shipping Condition
Gel Pack
-
Shelf Life
36 months
-
PubChem CID
25127112
-
-
SMILES
N#CC[C@@H](N1N=CC(C2=C3C(NC=C3)=NC=N2)=C1)C4CCCC4.O=P(O)(O)O
-
InChi
InChI=1S/C17H18N6.H3O4P/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16;1-5(2,3)4/h6,8-12,15H,1-5H2,(H,19,20,21);(H3,1,2,3,4)/t15-;/m1./s1
-
InChi Key
JFMWPOCYMYGEDM-XFULWGLBSA-N
-
-
MSDS Available
True